Secondary angiosarcomas (e.g., radiation and lymphedema induced) are characterized by Myc proto-oncogene (MYC) amplification and a subset also have FMS related receptor tyrosine kinase 4 (FLT4) amplification6. The gene discussed is FLT4; the disease is angiosarcoma.